In older patients with immune-mediated TTP, atypical features may delay diagnosisOctober 9, 2019Bleeding DisordersAnemia
Follow-up shows favorable results with acalabrutinib in MCLOctober 8, 2019Lymphoma & Plasma Cell Disorders
What is the optimal duration of maintenance in myeloma?October 8, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Targeted agents vs. chemoimmunotherapy as first-line treatment of CLLOctober 3, 2019Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Study finds no standard for treatment discontinuation in myelomaOctober 1, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Immunotherapies under investigation in newly diagnosed B-ALLOctober 1, 2019ALLLeukemia, Myelodysplasia, Transplantation
Second-generation anti-BCMA CAR T-cell therapy shows promise in myeloma trialSeptember 27, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
German CLLM1 study: 4-year data raise concerns about lenalidomide maintenanceSeptember 27, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
ICLL-07 trial: MRD-driven strategy yields prolonged survivalSeptember 27, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Daratumumab approved in combo with VTd for transplant-eligible multiple myelomaSeptember 26, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Subcutaneous and IV daratumumab combos appear comparable in myelomaSeptember 26, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Ongoing research aims to improve transplant outcomes in sickle cellSeptember 26, 2019AnemiaTransplantation
